Article Details

Zanubrutinib Plus Venetoclax Generates 100% ORR in Treatment-Naive Del17p/TP53+ CLL/SLL

Retrieved on: 2024-06-14 16:52:59

Tags for this article:

Click the tags to see associated articles and topics

Zanubrutinib Plus Venetoclax Generates 100% ORR in Treatment-Naive Del17p/TP53+ CLL/SLL. View article details on hiswai:

Excerpt

Rates of atrial fibrillation and hypertension were low,” presenting study ... atrial fibrillation/flutter (0%; 2%). TEAEs led to zanubrutinib ...

Article found on: www.onclive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up